
#172 Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars
Under the U.S. Supreme Court case FTC v. Actavis (2013), antitrust analysis of “reverse settlements” […]
Posted 12 months ago Tagged analysis antitrust biologics biosimilars competition economics generics intellectual property law litigation market payment pharmaceutical settlement
Under the U.S. Supreme Court case FTC v. Actavis (2013), antitrust analysis of “reverse settlements” […]
Posted 2 years ago Tagged ADR mediation settlement
Mediation is a tool that litigants can use to resolve disputes. What are the advantages […]
Posted 3 years ago Tagged antitrust class action competition drug intellectual property IP litigation patent pharmaceutical price product settlement
Battles in the pharmaceutical antitrust world have been increasingly heated, and to a great extent […]
Posted 3 years ago Tagged antitrust class action competition law court damages risk calculation settlement special master
In the antitrust bar, there are many litigations but few trials. Many antitrust cases are […]